HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Maria I Bokarewa Selected Research
Maria I Bokarewa Research Topics
Disease
29
Rheumatoid Arthritis
04/2022 - 08/2003
15
Inflammation (Inflammations)
01/2022 - 01/2002
10
Arthritis (Polyarthritis)
01/2022 - 08/2003
5
Pain (Aches)
09/2015 - 07/2012
5
Fibromyalgia (Fibrositis)
04/2015 - 07/2012
4
Neoplasms (Cancer)
05/2021 - 03/2011
4
Insulin Resistance
01/2021 - 06/2010
2
Arthralgia (Joint Pain)
01/2018 - 01/2018
2
Fatigue
02/2013 - 01/2013
1
Multiple Sclerosis
01/2022
1
Breast Neoplasms (Breast Cancer)
05/2021
1
Neoplasm Metastasis (Metastasis)
05/2021
1
Overweight
01/2021
1
Cardiovascular Diseases (Cardiovascular Disease)
01/2019
1
Hypertension (High Blood Pressure)
01/2019
1
Bone Resorption
11/2018
1
Disease Progression
11/2018
1
Body Weight (Weight, Body)
01/2018
1
Infectious Arthritis (Septic Arthritis)
01/2017
1
Experimental Arthritis
04/2016
1
Chronic Pain
01/2014
1
Epstein-Barr Virus Infections
12/2013
1
Autoimmune Diseases (Autoimmune Disease)
12/2013
1
Obesity
02/2013
1
Rheumatic Diseases (Rheumatism)
08/2012
1
Thrombosis (Thrombus)
08/2012
1
Atypical Hemolytic Uremic Syndrome
08/2012
1
Autoimmune Hepatitis
04/2012
1
Hepatitis
04/2012
1
Chronic Hepatitis C
04/2012
1
Liver Cirrhosis (Hepatic Cirrhosis)
04/2012
1
Non-alcoholic Fatty Liver Disease
04/2012
1
Fibrosis (Cirrhosis)
04/2012
1
Infections
04/2012
Drug/Important Bio-Agent (IBA)
12
Survivin
IBA
05/2021 - 01/2012
6
Proteins (Proteins, Gene)
FDA Link
01/2022 - 01/2006
6
Biomarkers (Surrogate Marker)
IBA
01/2018 - 08/2003
5
MicroRNAs (MicroRNA)
IBA
04/2022 - 01/2013
5
Autoantibodies
IBA
01/2018 - 04/2012
4
Interleukin-6 (Interleukin 6)
IBA
04/2022 - 01/2017
4
Insulin-Like Peptides
IBA
01/2019 - 10/2011
4
Antibodies
IBA
01/2018 - 04/2012
4
methylated bovine serum albumin (MBSA)
IBA
01/2017 - 01/2013
4
flt3 ligand protein (flt3 ligand)
IBA
03/2016 - 01/2012
4
Resistin
IBA
02/2013 - 06/2010
3
Cytokines
IBA
12/2020 - 06/2015
3
Adipokines
IBA
01/2016 - 02/2013
3
Oncogene Proteins (Oncogene Protein)
IBA
07/2015 - 01/2014
3
Insulin-Like Growth Factor I (IGF-1)
IBA
02/2013 - 10/2011
3
Rituximab (Mabthera)
FDA Link
10/2010 - 01/2009
2
RNA (Ribonucleic Acid)
IBA
04/2022 - 11/2014
2
Small Interfering RNA (siRNA)
IBA
01/2022 - 11/2014
2
Glucose (Dextrose)
FDA Link
Generic
01/2021 - 01/2020
2
C-Reactive Protein
IBA
01/2018 - 04/2012
2
Insulin (Novolin)
FDA Link
01/2018 - 10/2011
2
Immunoglobulin G (IgG)
IBA
04/2016 - 01/2010
2
fms-Like Tyrosine Kinase 3
IBA
03/2016 - 01/2012
2
Interleukins
IBA
06/2015 - 03/2011
2
S100 Calcium-Binding Protein A4
IBA
11/2014 - 12/2013
2
Leptin
IBA
01/2014 - 02/2013
2
Antigens
IBA
01/2013 - 01/2010
1
Cohesins
IBA
01/2022
1
geranylgeranyltransferase type-I (protein geranylgeranyltransferase)
IBA
01/2022
1
HLA-B27 Antigen (HLA B27 Antigen)
IBA
01/2022
1
rho GTP-Binding Proteins (rho GTP-Binding Protein)
IBA
01/2022
1
Catenins
IBA
01/2022
1
Estrogen Receptors
IBA
05/2021
1
Uncoupling Protein 1
IBA
01/2021
1
Triglycerides (Triacylglycerol)
IBA
01/2021
1
Receptor for Advanced Glycation End Products
IBA
01/2020
1
Nicotine
FDA Link
01/2020
1
Insulin Receptor Substrate Proteins
IBA
12/2018
1
Blood Glucose (Blood Sugar)
IBA
01/2018
1
NT157 compound
IBA
01/2017
1
Insulin Receptor
IBA
01/2017
1
NF-kappa B (NF-kB)
IBA
01/2017
1
interferon regulatory factor-8 (interferon consensus sequence binding protein)
IBA
03/2016
1
Methotrexate (Mexate)
FDA Link
Generic
09/2015
1
Pharmaceutical Preparations
IBA
09/2015
1
Interleukin-17 (Interleukin 17)
IBA
06/2015
1
Myosins (Myosin)
IBA
11/2014
1
src-Family Kinases
IBA
11/2014
1
Calcium
IBA
11/2014
1
Peptides (Polypeptides)
IBA
01/2014
1
Neuropeptide Y
IBA
01/2014
1
Nicotinic Receptors (Nicotinic Acetylcholine Receptor)
IBA
01/2014
1
Substance P
IBA
01/2014
1
Immunoglobulins (Immunoglobulin)
IBA
12/2013
1
Adiponectin
IBA
02/2013
1
Nerve Growth Factor (NGF)
IBA
02/2013
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
02/2013
1
Complement Factor H (Factor H)
IBA
08/2012
1
Anticoagulants
IBA
08/2012
1
Neuropeptides
IBA
07/2012
1
Collagen Type I (Type I Collagen)
IBA
05/2012
1
collagen type I trimeric cross-linked peptide
IBA
05/2012
1
Matrix Metalloproteinases (MMPs)
IBA
05/2012
1
Interferons
IBA
04/2012
Therapy/Procedure
3
Therapeutics
12/2020 - 04/2012
1
Intraperitoneal Injections
01/2013